Form 4: Insmed Director Carol Schafer Reports Acquisition of Restricted Stock Units

Director Carol Schafer reports acquisition of 5,058 Restricted Stock Units (RSUs) in Insmed Inc.

Summary

• On May 15, 2025, Carol Schafer, a director of Insmed Inc., acquired 5,058 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Insmed's common stock.
• The RSUs vest after one year, contingent upon Schafer remaining a board member and attending at least 75% of board meetings.
• Following the transaction, Schafer beneficially owns 63,317 shares of Insmed common stock directly.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a director is generally a good sign, indicating confidence in the company's future. However, it's a routine transaction.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest after one year, contingent upon Schafer remaining a board member and attending at least 75% of board meetings, incentivizing continued service and engagement.

Industry Context

Director stock acquisitions are common and are generally viewed positively by investors as they align management's interests with those of shareholders.

Key Dates

Keywords

Insmed, Director, Carol Schafer, RSU, Restricted Stock Units, Beneficial Ownership, Form 4, INSM